Accolades

Rankings

Ranked in Band 1 by Chambers China Life Sciences 2020 and Chambers Asia-Pacific Life Sciences 2020, Ropes & Gray has one of Asia’s most active and experienced China life sciences legal practices. Further recognition of our efforts in both the regulatory and transactional spaces within the region include:

  • Chambers Asia Pacific 2014-2020: Asia’s Leading Lawyers for Business: Recognized in Band 1 as a top-tier “Life Sciences” practice in the Asia-Pacific region and in China, with multiple attorneys ranked as leaders in the field.
  • Chambers Global 2008-2020: The World’s Leading Lawyers for Business: Ranked internationally as a leading “Life Sciences” practice, with multiple attorneys listed as leaders.
  • Legal 500 Asia Pacific 2018-2020: Recognized in Band 1 as a top-tier “Healthcare & Life Sciences” practice in China, with multiple attorneys ranked as leaders in the field.
  • In-House Community 2019: Named “Firm of the Year – China” for Life Sciences
  • China Law & Practice 2017: Named Ropes & Gray the international “Healthcare & Life Sciences Firm of the Year.”
  • Chambers USA 2007-2019: America’s Leading Lawyers for Business: Ranked as a leading national “Life Sciences” practice, with multiple attorneys listed as leaders.
  • Chambers USA 2008-2019: America’s Leading Lawyers for Business: FDA practice ranked in Washington, D.C. as a leading “Health Care: Pharmaceutical/Medical Products Regulatory” practice, with multiple attorneys listed as leaders.
  • U.S. News-Best Lawyers “Best Law Firms” 2016-2019: Ranked in the top tier nationally and by region in Massachusetts and New York for "Biotechnology Law;" ranked in the top tier by region in Washington, D.C. and nationwide for "FDA Law;" ranked in the top tier by region in Massachusetts and nationwide for “M&A Law.”
  • U.S News-Best Lawyers “Best Law Firms” 2016: Named “Firm of the Year” for Biotechnology Law.
  • Legal 500 U.S. 2013-2018: Ranked highly for “Healthcare: Life Sciences,” with multiple attorneys ranked as leaders in their field.
  • LMG Life Sciences Awards 2016-2018: Ranked highly for “Regulatory: FDA Pharmaceutical,” “Transactional: Corporate, Licensing & Collaborations, M&A, and Venture Capital” with multiple attorneys ranked as life sciences stars; ranked for “Regulatory: FDA Medical Devices” and “Government Investigations,” with multiple attorneys ranked as life sciences stars.
  • LMG Life Sciences Awards 2018: Winner of the “Finance & Transactional Impact Deal of the Year” and “Licensing & Collaboration Firm of the Year” awards.

In the News

As the premiere life sciences firm in China, we regularly represent clients in high-profile matters. In addition, our China-based attorneys are regularly cited in top daily and trade publications for comment and analysis on important issues, including:

Client Feedback

  • Chambers China Life Sciences:
    “Highly reputed practice offering expertise on both regulatory and transactional life science matters, as well as related IP and FCPA issues. Advises US and European companies on their Chinese operations. Acts for a strong roster of pharmaceutical, biotechnology and medical device companies.”

  • Chambers Global:  
    “[Ropes & Gray] has significant presence across Asia-Pacific and the USA and is well known for transactional capabilities and cross-border investments. Adept to handle contentious matters, it often assists pharmaceutical, medical device and biotechnology companies. [They are] also knowledgeable in IP and regulatory matters”

  • Chambers Asia-Pacific Life Sciences:
    “The firm's cross-border synergy and industry knowledge are core strengths. It was very helpful to have them all under one umbrella, the team worked very seamlessly. The market has evolved significantly and they are able to provide color on what's happening across Asia and globally.”
Cookie Settings